Ovarian cancer is the deadliest gynecological cancer, leading to over 152,000 deaths each
year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and …

Apolipoprotein AI (ApoA-I), the major protein component of high-density lipoproteins (HDL)
is a multifunctional protein, involved in cholesterol traffic and inflammatory and immune …

We demonstrate a handheld on-chip biosensing technology that employs plasmonic
microarrays coupled with a lens-free computational imaging system towards multiplexed …

Whispering gallery modes (WGMs) have been exploited for a broad range of sensing
applications. However, the vast majority of WGM sensors consist of passive resonators …

Ovarian cancer is a silent cancer which rate survival mainly relays in early stage detection.
The discovery of reliable ovarian cancer biomarkers plays a crucial role in the disease …

Ovarian cancer is the eighth-most common cause of death among women worldwide. In the
absence of distinctive symptoms in the early stages, the majority of women are diagnosed in …

Mass spectrometry-based multiple reaction monitoring (MRM) quantitation of proteins can
dramatically impact the discovery and quantitation of biomarkers via rapid, targeted …

Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological
cancers. Less than 30% of women with advanced stage disease survive long‐term. When …

Background and Objective Analysis of inflammatory biomarkers in saliva could offer an
attractive opportunity for the diagnosis of different systemic conditions specifically in …

Ovarian cancer is the fourth most common cancer in women in the Western world. In a pilot
scale study, we highlight changes in the total serum glycome of patients with advanced …